E-LIB Suche - Ergebnisse für: Vidor, Emmanuel

1

Safety and immunogenicity of a new formulation of a pentava..:

Aloysia D'Cor, Naveena ; Siddaiah, Prashanth ; Mohapatra, Satyajit...
PLOS ONE. 18 (2023) 8 - p. e0284898 , 2023

2

Post-Marketing Surveillance of Tetravalent Diphtheria-Tetan..:

Choe, Young June ; Vidor, Emmanuel ; Manson, Christine
Infectious Diseases and Therapy. 11 (2022) 4 - p. 1479-1492 , 2022

Link: https://doi.org/10.1007/..

3

A combined DTaP-IPV vaccine (Tetraxim®/Tetravac®) used as s..:

Huoi, Catherine ; Vargas-Zambrano, Juan ; Macina, Denis.
Expert Review of Vaccines. 21 (2022) 9 - p. 1215-1231 , 2022

Link: https://doi.org/10.1080/..

4

Hepatitis B surface antigen prevalence and the rates of mot..:

Marjenberg, Zoe ; Wright, Ciara ; Pooley, Nick...
International Journal of Infectious Diseases. 124 (2022) - p. 65-75 , 2022

Link: https://doi.org/10.1016/..

5

Immunogenicity and safety of a hexavalent pediatric vaccine..:

Koen, Anthonet ; Madhi, Shabir ; Lyabis, Olga...
Human Vaccines & Immunotherapeutics. 17 (2020) 6 - p. 1770-1778 , 2020

Link: https://doi.org/10.1080/..

6

Immunogenicity and safety of a DTaP-IPV/Hib pentavalent vac..:

Nakayama, Tetsuo ; Vidor, Emmanuel ; Tsuzuki, Daisuke...
Journal of Infection and Chemotherapy. 26 (2020) 7 - p. 651-659 , 2020

Link: https://doi.org/10.1016/..

7

Immunogenicity and safety of a fully liquid DTaP-IPV-HB-PRP..:

Kim, Yun-Kyung ; Vidor, Emmanuel ; Kim, Hwang Min...
Vaccine. 35 (2017) 32 - p. 4022-4028 , 2017

Link: https://doi.org/10.1016/..

8

Immunogenicity and safety of a liquid hexavalent vaccine in..:

Chhatwal, Jugesh ; Lalwani, Sanjay ; Vidor, Emmanuel
Indian Pediatrics. 54 (2016) 1 - p. 15-20 , 2016

Link: https://doi.org/10.1007/..

9

Immunogenicity of Two Different Sequential Schedules of Ina..:

Li, Rong-Cheng ; Li, Chang-Gui ; Wang, Hai-Bo...
Journal of the Pediatric Infectious Diseases Society. 5 (2015) 3 - p. 287-296 , 2015

Link: https://doi.org/10.1093/..

10

Diphtheria, tetanus and poliovirus antibody persistence 5 y..:

Gajdos, Vincent ; Vidor, Emmanuel ; Richard, Patrick..
Vaccine. 33 (2015) 32 - p. 3988-3996 , 2015

Link: https://doi.org/10.1016/..

11

List of Contributors:

, In: Vaccines,

Abrignani, Sergio ; Ahmed, Sohail ; Anderson, Teresa A.... - p. xii-xviii , 2013

Link: https://doi.org/10.1016/..

12

Poliovirus vaccine—inactivated:

, In: Vaccines,

Vidor, Emmanuel ; Plotkin, Stanley A. - p. 573-597 , 2013

Link: https://doi.org/10.1016/..

13

Randomized controlled study of fractional doses of inactiva..:

Cadorna-Carlos, Josefina ; Vidor, Emmanuel ; Bonnet, Marie-Claude
International Journal of Infectious Diseases. 16 (2012) 2 - p. e110-e116 , 2012

Link: https://doi.org/10.1016/..

14

Repertoire of antibodies against type 1 poliovirus in human..:

Rezapkin, Gennady ; Neverov, Alexander ; Cherkasova, Elena...
Journal of Virological Methods. 169 (2010) 2 - p. 322-331 , 2010

Link: https://doi.org/10.1016/..

15

L'apport du laboratoire dans les essais cliniques vaccinaux:

Vidor, Emmanuel ; Crevat, Denis
Revue Francophone des Laboratoires. 2006 (2006) 381 - p. 47-52 , 2006

Link: https://doi.org/10.1016/..